Elevation Oncology shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Elevation Oncology
Tip: Access up to 7 years of quarterly data
All positions including Elevation Oncology held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Elevation Oncology by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $12k | 19k | 0.60 |
| 2024-06-30 | $52k | 19k | 2.70 |
| 2024-03-31 | $1.3k | 245 | 5.13 |
| 2023-12-31 | $129 | 241 | 0.54 |
| 2023-09-30 | $152 | 229 | 0.66 |
| 2023-06-30 | $148 | 98 | 1.52 |
| 2022-12-31 | $86 | 90 | 0.96 |
| 2022-09-30 | $0 | 88 | 0.00 |
| 2022-06-30 | $0 | 42 | 0.00 |
| 2022-03-31 | $0 | 39 | 0.00 |
| 2021-12-31 | $0 | 38 | 0.00 |
| 2021-09-30 | $0 | 38 | 0.00 |